Indo US Bio-TechNSE:INDOUS -2.29%63 PEG Ratio is 0.72 as of Jul. 11, 2026, which is 23% below its 10-year median of 0.94. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹312.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 108 Agriculture companies, Indo US Bio-Tech ranks better than 75% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Indo US Bio-Tech's PEG Ratio or its related term are showing as below:
NSE:INDOUS'
s PEG Ratio Range Over the Past 10 Years
Min: 0.71 Med: 0.94 Max: 2.27
Current: 0.71
During the past 13 years, Indo US Bio-Tech's highest PEG Ratio was 2.27. The lowest was 0.71. And the median was 0.94.
NSE:INDOUS's PEG Ratio is ranked better than 75% of 108
companies
in the Agriculture industry
Industry Median: 1.325
vs NSE:INDOUS: 0.71
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Indo US Bio-Tech (NSE:INDOUS) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Indo US Bio-Tech PEG Ratio Related Terms
Indo US Bio-Tech PEG Ratio Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Indo US Bio-Tech's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech PEG Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Indo US Bio-Tech (NSE:INDOUS) has a PEG Ratio of 0.72 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Indo US Bio-Tech and its competitors. This is 23% below median its historical median of 0.94. Over the past decade, Indo US Bio-Tech's PEG Ratio has ranged from 0.71 to 2.27. According to the industry distribution chart, Indo US Bio-Tech ranks #27 out of 108 companies in the Agriculture industry, placing it in the top 25%.
Is Indo US Bio-Tech's PEG Ratio too high?
Indo US Bio-Tech's current PEG Ratio of 0.72 is 23% below median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 2.27. The Agriculture industry median PEG Ratio is 1.33. Indo US Bio-Tech's value of 0.72 is 45.7% below this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #27 out of 108 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's PEG Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #27 out of 108 companies for PEG Ratio. This places Indo US Bio-Tech in the top 25% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.33. Indo US Bio-Tech's value of 0.72 is 45.7% below this benchmark. Historically, Indo US Bio-Tech's own PEG Ratio has ranged from 0.71 to 2.27 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 1.33, Indo US Bio-Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for an Agriculture company?
The median PEG Ratio among Agriculture companies is 1.33, based on 108 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current PEG Ratio of 0.72 is 45.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median PEG Ratio is 1.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current PEG Ratio is 0.72, which is 23% below median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹312.23, compared to a current price of ₹87.52 — trading 72% below its estimated fair value. The current PEG Ratio is 0.72, which is 23% below median its 10-year median of 0.94 and 45.7% below the Agriculture industry median of 1.33. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current PEG Ratio is 0.72 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹87.52 is trading 72% below its estimated GF Value™ of ₹312.23.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
PEG Ratio: 0.72 (23% below median its 10-year median of 0.94)
GF Value™: ₹312.23 vs. price of ₹87.52 (72% below fair value)
Industry Position: 45.7% below the Agriculture median (#27 of 108)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
